Caso sector Pharma


  • 20 May 2015
  • Neuro-discovery, Neuro-experience, Sales reconduction

Sales Growth in Mature Products and New Launches

Spanish pharmaceutical group leader at national and international level


Renewal of sales of mature products -both for patent expiration and obsolescence by new formulas- that, while had important falls in sales, still posed a significant revenue for the company.


KBC made a neuro-discovery and a whole neuro-experiential development for several products in maturity phase, which was later adopted as a methodology for products at that stage of their life cycle. Subsequently made a similar job for maximizing the reach and effectiveness in launching a new product.


1- Rebound/significant annual increase in sales of products with important turnovers but decreases (for their maturity / obsolescence) in previous years.
2- Substantial increase in sales in a new product launch in comparison with best previous experiences.
3- Significant reduction in the Time-To-Market and marketing and trade/commercial costs, both in launching new products and in the re-launch of existing and/or mature ones.

En utilizamos cookies para mejorar tu experiencia de navegación. Más información sobre las cookies

Los ajustes de cookies de esta web están configurados para "permitir cookies" y así ofrecerte la mejor experiencia de navegación posible. Si sigues utilizando esta web sin cambiar tus ajustes de cookies o haces clic en "Aceptar" estarás dando tu consentimiento a esto.